Narayana Hrudayalaya Limited has recorded a substantial block trade on the National Stock Exchange (NSE), highlighting significant institutional trading activity in the healthcare sector stock.

Block Trade Details

The transaction involved a considerable volume and value, demonstrating institutional interest in the company's shares.

Market Significance

Block trades are typically executed by institutional investors, mutual funds, or large stakeholders looking to buy or sell significant quantities of shares without impacting the regular market price. These transactions are usually conducted outside regular trading hours or through special trading windows.

The substantial value of ₹81.53 crores indicates meaningful institutional participation in Narayana Hrudayalaya's stock. Such large-volume transactions often reflect strategic portfolio adjustments by institutional investors or potential stake changes in the company.

Transaction Overview

The block trade represents a significant portion of trading activity for the healthcare company. At ₹1,913.00 per share, the transaction price provides insight into the institutional valuation of the stock at the time of execution.

Block trades serve as important market indicators, often signaling institutional confidence or strategic repositioning in specific stocks. For Narayana Hrudayalaya, this transaction demonstrates continued institutional interest in the healthcare sector and the company's market position.

Narayana Hrudayalaya Limited's Board of Directors has formally approved a comprehensive scheme of arrangement for the demerger of clinical services from its subsidiary NH Integrated Care Private Limited, following regulatory compliance requirements under SEBI regulations.

Board Meeting Outcome

The Board of Directors meeting held on December 12, 2025, considered and approved the Scheme of Arrangement between NH Integrated Care Private Limited (Demerged Company/NHIC) and Narayana Hrudayalaya Limited (Resulting Company/NHL) under Sections 230 to 232 of the Companies Act, 2013. The meeting was conducted with full regulatory compliance under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Demerger Structure and Financial Impact

The scheme provides for the demerger of the Clinical Services undertaking from NHIC into NHL on a going-concern basis. The Clinical Services undertaking comprises 10 clinics located in Bengaluru that focus on delivering accessible, preventive, and continuous integrated care.

Notably, the demerger excludes the Narayana Aarogyam preventive healthcare platform, which will remain with NHIC. This platform provides health screening, risk assessment, wellness coaching, and continuous monitoring services based on early detection and intervention prior to disease onset.

Strategic Rationale and Benefits

The separation strategy aims to create focused business entities with distinct operational models. The demerger will allow the Demerged Company to exclusively pursue the preventive healthcare business, enabling sharper focus and growth in this niche segment.

The separation of the Clinical Services undertaking will enable the Demerged Company to concentrate exclusively on developing the Aarogyam preventive healthcare platform through digital-first, AI-powered service delivery and comprehensive screening programs.

Regulatory Compliance and Implementation

The scheme has been filed with stock exchanges in compliance with SEBI regulations and circulars, including SEBI Circular Nos. SEBI/HO/CFD/POD-2/P/CIR/2023/93 dated June 20, 2023, and SEBI/HO/DDHS/DDHS-PoD-1/P/CIR/2024/48 dated May 21, 2024.

Since NHIC is a wholly-owned subsidiary of NHL, there will be no change in the shareholding pattern of the Resulting Company. The scheme is subject to receipt of necessary statutory and regulatory approvals, including approval from the jurisdictional National Company Law Tribunal (NCLT) and other regulatory authorities as applicable.